本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Denali Therapeutics Inc.

16.50
+0.25001.54%
盤後16.500.00000.00%16:20 EDT
成交量:152.12萬
成交額:2,507.12萬
市值:23.96億
市盈率:-6.42
高:16.83
開:16.18
低:16.07
收:16.25
資料載入中...
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]